LENZ THERAPEUTICS, INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
LENZ THERAPEUTICS, INC. (LENZ) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$71.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2024-02-27
- LENZ THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2023-12-31 was $0.00.
- LENZ THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2023-09-30 was $0.00.
- LENZ THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2022-12-31 was $0.00.
- LENZ THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2022-09-30 was $0.00.
- LENZ THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was -$71.00K.
- LENZ THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | -$71.00K 10-K · filed 2024-02-27 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | -$71.00K 10-Q · filed 2023-11-13 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |